Patch-free Occlusion Therapy

Launched by RETINA FOUNDATION OF THE SOUTHWEST · Jun 27, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to treat amblyopia, also known as "lazy eye," in young children. Instead of using traditional adhesive patches to cover the stronger eye, the study is testing a patch-free method to see if it helps improve vision more effectively. The researchers want to find out if this new approach not only leads to better vision outcomes but also encourages children to stick with their treatment.

To be eligible for the study, children must be between 3 and 10 years old and diagnosed with specific types of amblyopia. They should have been wearing glasses for at least 8 weeks, and their vision must not have changed during that time. Children with certain health issues or severe vision problems will not be able to participate. Families who join the study can expect to follow the new treatment method without the standard patches, and the study is currently looking for participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 3-10 years (3-7 primary cohort)
• • male and female
• • strabismic, anisometropic, or combined mechanism amblyopia (visual acuity: 0.3-0.8 logMAR)
• • interocular visual acuity difference ≥0.3 logMAR
• • wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart
• • child's ophthalmologist and family willing to forgo standard patching treatment during the study
• Exclusion Criteria:
• • Prematurity ≥8 wk
• • coexisting ocular or systemic disease
• • developmental delay
• • myopia \> -3.00D